GoodRx Holdings, Inc. Class A Common Stock (GDRX) Stock Price
GDRXStock
$3.36−13.85%52W
Market Cap$1.15B
P/E37.66x
PEG Ratio—
Div yield—
Beta1.69
GDRX Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)40.77%
Price vs S&P 500 (4W)0.44%
VGM Score49.07
P/E Ratio (Annual)37.66x
GDRX Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.08 | $0.08 | +0.38%(+$0.00) | |
| Q1 2026 | $0.07 | $0.07 | -2.18%(-$0.00) | |
| Q4 2025 | $0.09 | $0.09 | -1.73%(-$0.00) | |
| Q3 2025 | $0.09 | $0.08 | -12.26%(-$0.01) | |
| Q2 2025 | $0.10 | $0.09 | -9.18%(-$0.01) |
GDRX Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.57
3.57
3.57
3.57
Industry Peers — Computer Processing & Data(94)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
GDRXGoodRx Holdings, Inc. Class A Common Stock | C | D | B | 1.5x | -1.8% | 90.8% | 9.5% | $3.36 |
| ADPAutomatic Data Processing | D | C | B | 5.2x | 6.7% | 46.5% | 26.3% | $288.90 |
| WDAYWorkday, Inc. Class A Common Stock | D | B | B | 4.7x | 13.3% | 75.8% | 10.7% | $190.81 |
| RDDTReddit, Inc. | F | A | C | 10.8x | 66.6% | 91.4% | 28.3% | $156.14 |
| VRSKVerisk Analytics, Inc. Common Stock | D | D | B | 7.9x | 5.0% | 70.2% | 43.4% | $190.90 |
| TOSTToast, Inc. | D | A | B | 2.7x | 23.0% | 26.7% | 6.3% | $31.62 |
| HNGEHinge Health, Inc. | F | B | A | 11.1x | 10.2% | 84.5% | 13.0% | $99.16 |
| RNGRINGCENTRAL, INC. | C | C | A | 2.4x | 5.2% | 71.8% | 6.7% | $75.44 |
| BILIBilibili Inc. American Depositary Shares | C | B | D | 1.3x | 6.9% | 37.0% | 4.5% | $14.07 |
| PEGAPegasystems Inc | D | C | C | 3.3x | 3.6% | 75.6% | 9.9% | $34.54 |
| APLDApplied Digital Corporation Common Stock | F | A | D | 6.4x | 457.0% | 20.2% | -35.6% | $18.05 |
About GoodRx Holdings, Inc. Class A Common Stock
GoodRx operates a digital healthcare platform that enables consumers to compare prescription prices and access negotiated savings across U.S. pharmacies. The company generates revenue primarily from pharmacy benefit managers that manage prescription transactions, while diversifying through telehealth services, pharmaceutical manufacturer solutions, and subscription offerings.